CRISPR-Cas9: A Nobel Prize and an Ongoing Patent Battle October 22, 2020 | By Andrew Park Within the last decade, the genome editor known as CRISPR-Cas9, short for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9, has become one Read More Patent Law IP crispr
